Group Members
/f.eu1.jwwb.nl%2Fpublic%2Fy%2Fg%2Fq%2Ftemp-wibtyspuysxvsaokmyjj%2Ftd4c07%2FAllott_Profile.jpg)
Dr Louis Allott (Group Leader)
Lecturer in Translational Radiopharmaceutics
Louis completed his master’s degree in chemistry (MChem) at the University of Hull in 2011 and continued studying for a PhD in PET Radiochemistry (2011 – 2014). He started post-doctoral research in the Division of Radiotherapy and Imaging, Institute of Cancer Research (2014 – 2017) under the supervision of Dr Graham Smith; followed by a position with Prof Eric Aboagye in the Faculty of Medicine, Imperial College London as a Post-doctoral Research Associate and Chemistry Team Leader (2017 – 2020). In January 2021, Louis returned to the University of Hull as Lecturer in Translational Radiopharmaceutics where he joined the team to set up the new Molecular Imaging Research Centre and establish a new research group. His group develops small-molecule and biomolecule PET radiochemistry, advanced automated radiosynthesis protocols and novel radiopharmaceuticals for clinical translation.
/f.eu1.jwwb.nl%2Fpublic%2Fy%2Fg%2Fq%2Ftemp-wibtyspuysxvsaokmyjj%2Flt33ju%2Fdc2bc385-b498-4b1e-ae5c-f8ef86251a75.jpg)
Miss Zixuan Yang
PhD Student - Imperial College London (Co-supervision)
Zixuan (Noble) is working on a collaborative project between the Allott and Aboagye group where she develops new targeted therapeutics for cancer. She is based at Imperial College London.
Collaborators
Prof Eric O. Aboagye - Imperial College London, Faculty of Medicine
Prof Steve Archibald - University of Hull